Pharmaceuticals discovered with AI
EFFICIENT DRUG DISCOVERY & DEVELOPMENT
twoXAR Pharmaceuticals is a drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 18 diseases. twoXAR saves years in drug development while generating a 30x hit rate at in vivo efficacy milestones over traditional methods.
twoXAR Pharmaceuticals
Drug Discovery and Development Overview
May 2020
LATEST NEWS
TXR-311 Shows Promising Preclinical Efficacy and Safety in Hepatocellular Carcinoma
Targeted Oncology
June 26, 2020
LATEST EVENTS
Xconomy: Xcelerating Life Sciences San Francisco
San Francisco, CA (DIGITAL EVENT)
June 25, 2020
twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward"
Digital Meeting
June 8-12, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin describes how the company approaches drug discovery.
Digital
May 19, 2020
twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.
© 2020 twoXAR, Incorporated | All Rights Reserved